Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Epidermodysplasia verruciformis (EV) is an autosomal recessive dermatosis characterized by abnormal susceptibility to human papillomaviruses (HPVs) and a high rate of progression to squamous cell carcinoma on sun-exposed skin. Additionally we are shipping Transmembrane Channel-Like 6 Proteins (5) and many more products for this protein.
Showing 10 out of 47 products:
Human Polyclonal TMC6 Primary Antibody for IHC, WB - ABIN351052
Kurima, Yang, Sorber, Griffith: Characterization of the transmembrane channel-like (TMC) gene family: functional clues from hearing loss and epidermodysplasia verruciformis. in Genomics 2003
Show all 5 references for ABIN351052
Human Polyclonal TMC6 Primary Antibody for EIA, IHC (p) - ABIN499808
Majewski, Jab?o?ska, Orth: Epidermodysplasia verruciformis. Immunological and nonimmunological surveillance mechanisms: role in tumor progression. in Clinics in dermatology 1997
Show all 4 references for ABIN499808
Human Polyclonal TMC6 Primary Antibody for EIA, IHC (p) - ABIN499806
Keresztes, Mutai, Heller: TMC and EVER genes belong to a larger novel family, the TMC gene family encoding transmembrane proteins. in BMC genomics 2003
Show all 4 references for ABIN499806
Mouse (Murine) Polyclonal TMC6 Primary Antibody for IHC, WB - ABIN350029
Carninci, Kasukawa, Katayama, Gough, Frith, Maeda, Oyama, Ravasi, Lenhard, Wells, Kodzius, Shimokawa, Bajic, Brenner, Batalov, Forrest, Zavolan, Davis, Wilming, Aidinis, Allen, Ambesi-Impiombato et al.: The transcriptional landscape of the mammalian genome. ... in Science (New York, N.Y.) 2005
Show all 3 references for ABIN350029
Findings suggest that SNP in EVER 1 may be involved in the development of premalignant skin lesions that harbour beta-HPV, perhaps giving rise to SCC (show CYP11A1 Antibodies) tumours that have lost beta-HPV gene expression during progression
TMC6/EVER1 and TMC8/EVER2 (show TMC8 Antibodies) are known to be involved in the development of EV.
TMC6 variants are associated with diminished age-of-onset of P. aeruginosa airway infection in children with cystic fibrosis (show S100A8 Antibodies).
EV is also a rare autosomal recessive genodermatosis involving susceptibility to human papillomavirus (HPV) infections and squamous cell carcinoma, caused in most cases by homozygous mutations in EVER1 or EVER2 (show TMC8 Antibodies).
Expression of both EVER1 and EVER2 (show TMC8 Antibodies) in B cells is activated immediately after Epstein-Barr virus (EBV) infection, whereas at later stages, it is strongly repressed by latent membrane protein 1-activated NF-kappaB (show NFKB1 Antibodies) signaling.
Data support the involvement of the TMC6/8 region in cervix cancer susceptibility.
Mutations in EVER1 are associated with epidermodysplasia verruciformis.
four mutations in recurrent respiratory papillomatosis patients might indicate that EVER 1 alleles are not associated with susceptibility to RRP (show RRBP1 Antibodies)
The growing number of mutations in epidermodysplasia verruciformis (EV) pedigrees supports the hypothesis that EVER1 and EVER2 (show TMC8 Antibodies) are the molecular basis of EV.
HPV16 E5 protein binds to EVER and ZnT-1 (show SLC30A1 Antibodies) and blocks their negative regulation
Epidermodysplasia verruciformis (EV) is an autosomal recessive dermatosis characterized by abnormal susceptibility to human papillomaviruses (HPVs) and a high rate of progression to squamous cell carcinoma on sun-exposed skin. EV is caused by mutations in either of two adjacent genes located on chromosome 17q25.3. Both of these genes encode integral membrane proteins that localize to the endoplasmic reticulum and are predicted to form transmembrane channels. This gene encodes a transmembrane channel-like protein with 10 transmembrane domains and 2 leucine zipper motifs.
transmembrane channel-like 6
, epidermodysplasia verruciformis 1
, transmembrane channel-like protein 6
, transmembrane channel-like protein 6-like
, epidermodysplasia verruciformis protein 1
, expressed in activated T/LAK lymphocytes
, protein LAK-4